Home
Caribou Biosciences

Caribou Biosciences Market Share Analysis for June 2026

caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.

Science and Education > Biology

Domaincariboubio.com

Year Founded2011

Employees51 - 200

Annual Revenue$5M - $10M

Caribou Biosciences

Caribou Biosciences (including company regionals)

cariboubio.com

See more website traffic and engagement information

Caribou Biosciences Revenue up to June 2026 is 5M - 10M

revenue generated by Caribou Biosciences top domains

Caribou Biosciences top domains revenue over 3 years

Revenue for Caribou Biosciences top domains

cariboubio.com5M - 10M

See more with Sales Intelligence

Total visits to Caribou Biosciences's top domains

Understand Caribou Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cariboubio.com8.8K

See more with Sales Intelligence

Avg. visit duration in Caribou Biosciences's top domains

Analyze Caribou Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cariboubio.com00:00:33

See more with Sales Intelligence

Avg. pageviews on Caribou Biosciences's top domains

See how Caribou Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cariboubio.com1.64

See more with Sales Intelligence

Caribou Biosciences top competitors by domain

Top similar sites in June 2026, ranked by their affinity

idtdna.comCompany NameIntegrated DNA TechnologiesEmployees1001 - 5000HQUnited States, Iowa, CoralvilleAnnual revenue$200M - $500MTotal visits492KScience and Education > Biology

Top technologies used by Caribou Biosciences

These are the website technologies, by industry, used by Caribou Biosciences top domains

Content Management System (3)

WordPress

Email Services (2)

G Suite

Mobile (2)

Meta Viewport

Recruitment (2)

Greenhouse

More Technologies

8

See all

News & Signals from Caribou Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCaribou Biosciences, Inc. attended event H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on Jun 30th '26.BERKELEY, Calif., June 29, 2026 (GLOBE NEWSWIRE) - Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou's president and chief executive officer, will participate in a fireside chat at the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on June 30, 2026, at 10:00 am ET.

NewsCaribou Biosciences, Inc. will attend event 2026 Jefferies Global Healthcare Conference on Jun 4th '26.Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou's president and chief executive officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026, at 2:35pm ET in New York.

NewsCaribou Biosciences, Inc. attends event BofA Securities 2025 Health Care Conference.BERKELEY, Calif., May 06, 2025 (GLOBE NEWSWIRE) - Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou's president and chief executive officer, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on May 13th at 2:35 PM PDT.